IPOPLUS

42.93

+0.2 +0.47%

17 Jun 2026

NSE Listed · Pharmaceuticals

Medico Remedies Limited (MEDICO)

Volume: 12,074Avg Vol 1W: 12,260Avg Vol 1M: 18,73452W Range:30.2256.88
₹42.93 0.47%
Key Ratios
Updated 2h ago
Market Cap
Current Price₹42.93
Previous Close₹42.73
High / Low (52w)₹56.88 / ₹30.22
Volume12,074
Avg Vol (1W)12,260
Avg Vol (1M)18,734
Stock P/E42.7
Book Value₹9.09
Dividend Yield
ROE
ROA
Revenue (TTM)
Revenue Growth
Profit Margin
Total Debt
Shares Outstanding
Face Value₹2
EPS (TTM)₹0.71
P/B4.54
Debt / Equity
50 DMA₹43.35
200 DMA₹43.97
Day change+0.47%
Price Chart
42.93 11.15% · 1Y
553348.4L
2025-10-01
2026-06-16

20-day avg volume: 20K shares

Pros
  • Net profit is growing year over year.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021
Revenue₹57 Cr₹59 Cr₹53 Cr₹38 Cr₹41 Cr₹39 Cr₹39 Cr₹31 Cr₹41 Cr₹30 Cr₹42 Cr₹31 Cr₹28 Cr₹39 Cr₹40 Cr₹33 Cr₹32 Cr₹30 Cr₹30 Cr₹29 Cr
EBITDA₹9 Cr₹4 Cr₹4 Cr₹3 Cr₹6 Cr₹4 Cr₹2 Cr₹2 Cr₹4 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹4 Cr₹4 Cr₹1 Cr₹3 Cr₹2 Cr₹2 Cr₹0 Cr
Net Profit₹6 Cr₹3 Cr₹3 Cr₹2 Cr₹4 Cr₹3 Cr₹2 Cr₹2 Cr₹3 Cr₹1 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹3 Cr₹0 Cr₹2 Cr₹1 Cr₹2 Cr₹0 Cr
EPS0.710.350.310.220.520.320.190.190.370.170.290.160.211.361.730.221.130.614.020.09
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹154 Cr₹147 Cr₹144 Cr₹123 Cr₹123 Cr₹91 Cr
EBITDA₹15 Cr₹12 Cr₹11 Cr₹7 Cr₹5 Cr₹3 Cr
Net Profit₹10 Cr₹8 Cr₹7 Cr₹5 Cr₹3 Cr₹2 Cr
EPS1.2210.870.581.563.93
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹120 Cr₹96 Cr₹87 Cr₹77 Cr₹76 Cr₹75 Cr
Total Liabilities₹57 Cr₹44 Cr₹44 Cr₹41 Cr₹43 Cr₹45 Cr
Equity₹62 Cr₹52 Cr₹44 Cr₹37 Cr₹32 Cr₹30 Cr
Total Debt₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹5 Cr₹5 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operating₹9 Cr₹6 Cr₹11 Cr₹8 Cr₹-10 Cr
Investing₹-3 Cr₹-3 Cr₹-7 Cr₹-2 Cr₹-17 Cr
Financing₹-1 Cr₹0 Cr₹-2 Cr₹-6 Cr₹18 Cr
Free Cash Flow₹9 Cr₹6 Cr₹11 Cr₹8 Cr₹-10 Cr
Shareholding
Promoter 61.38% Institutions 0.03% Public 38.59%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search